Skip to content

Source filing unavailable

Q4 2018 · —
Revenue—
Net Income-$450.00no prior Q4 2017 on fileN/M vs Q3 2018
EPS Diluted$0.00no prior Q4 2017 on fileN/M vs Q3 2018
Operating Cash Flow-$450—
Free Cash Flowderived-$12,649,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q4 2017 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Immunovant, Inc. · CIK 1764013 · Engraved from SEC EDGAR